Holdings of the Fund as of 4/10/2026
Total Number of Holdings (excluding cash): 49
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
752 |
$67,995.84 |
3.51% |
| Align Technology, Inc. |
ALGN |
016255101 |
338 |
$58,521.32 |
3.02% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$54,422.57 |
2.81% |
| Penumbra, Inc. |
PEN |
70975L107 |
163 |
$53,752.51 |
2.77% |
| Masimo Corporation |
MASI |
574795100 |
294 |
$52,426.08 |
2.71% |
| Waters Corporation |
WAT |
941848103 |
159 |
$50,880.00 |
2.63% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,985 |
$49,434.92 |
2.55% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,046 |
$46,077.75 |
2.38% |
| Alcon Inc. |
ALC.SW |
H01301128 |
589 |
$45,970.72 |
2.37% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
576 |
$44,853.12 |
2.31% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
99 |
$44,611.38 |
2.30% |
| The Cooper Companies, Inc. |
COO |
216648501 |
622 |
$44,292.62 |
2.29% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,550 |
$44,116.90 |
2.28% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
599 |
$43,834.82 |
2.26% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
33 |
$43,725.33 |
2.26% |
| Revvity, Inc. |
RVTY |
714046109 |
482 |
$43,278.78 |
2.23% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
393 |
$41,976.43 |
2.17% |
| Teleflex Incorporated |
TFX |
879369106 |
356 |
$42,146.84 |
2.17% |
| DexCom, Inc. |
DXCM |
252131107 |
654 |
$41,869.08 |
2.16% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
163 |
$41,817.65 |
2.16% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
449 |
$41,810.88 |
2.16% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,415 |
$40,547.10 |
2.09% |
| Steris Plc |
STE |
G8473T100 |
180 |
$40,064.40 |
2.07% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
81 |
$40,184.91 |
2.07% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
143 |
$39,932.75 |
2.06% |
| Danaher Corporation |
DHR |
235851102 |
210 |
$39,818.10 |
2.05% |
| Stryker Corporation |
SYK |
863667101 |
117 |
$39,680.55 |
2.05% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
196 |
$39,144.83 |
2.02% |
| Medtronic Plc |
MDT |
G5960L103 |
446 |
$38,895.66 |
2.01% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,205 |
$37,501.71 |
1.94% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
539 |
$36,792.14 |
1.90% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
157 |
$36,343.23 |
1.88% |
| Agilent Technologies, Inc. |
A |
00846U101 |
312 |
$35,898.72 |
1.85% |
| ResMed Inc. |
RMD |
761152107 |
156 |
$35,703.72 |
1.84% |
| Becton, Dickinson and Company |
BDX |
075887109 |
228 |
$35,162.16 |
1.81% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,540 |
$34,853.37 |
1.80% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
778 |
$34,461.17 |
1.78% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,560 |
$34,372.24 |
1.77% |
| BioMerieux |
BIM.FP |
F1149Y232 |
320 |
$33,850.11 |
1.75% |
| Baxter International Inc. |
BAX |
071813109 |
1,939 |
$33,253.85 |
1.72% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
485 |
$32,616.25 |
1.68% |
| Abbott Laboratories |
ABT |
002824100 |
321 |
$32,196.30 |
1.66% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,434 |
$29,918.98 |
1.54% |
| Cochlear Limited |
COH.AU |
Q25953102 |
229 |
$27,896.96 |
1.44% |
| Boston Scientific Corporation |
BSX |
101137107 |
446 |
$27,558.34 |
1.42% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,487 |
$26,821.23 |
1.38% |
| Insulet Corporation |
PODD |
45784P101 |
135 |
$26,585.55 |
1.37% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
860 |
$26,162.06 |
1.35% |
| US Dollar |
$USD |
|
3,424 |
$3,423.54 |
0.18% |
| Australian Dollar |
$AUD |
|
631 |
$445.99 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|